Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Robust meta-analytic-predictive priors in clinical trials with historical control information.

Schmidli H, Gsteiger S, Roychoudhury S, O'Hagan A, Spiegelhalter D, Neuenschwander B.

Biometrics. 2014 Oct 29. doi: 10.1111/biom.12242. [Epub ahead of print]

PMID:
25355546
[PubMed - as supplied by publisher]
2.

Population pharmacokinetics of dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its metabolites.

Ouellet D, Gibiansky E, Leonowens C, O'Hagan A, Haney P, Switzky J, Goodman VL.

J Clin Pharmacol. 2014 Jun;54(6):696-706. doi: 10.1002/jcph.263. Epub 2014 Jan 17.

PMID:
24408395
[PubMed - in process]
3.

Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.

Ascierto PA, Minor D, Ribas A, Lebbe C, O'Hagan A, Arya N, Guckert M, Schadendorf D, Kefford RF, Grob JJ, Hamid O, Amaravadi R, Simeone E, Wilhelm T, Kim KB, Long GV, Martin AM, Mazumdar J, Goodman VL, Trefzer U.

J Clin Oncol. 2013 Sep 10;31(26):3205-11. doi: 10.1200/JCO.2013.49.8691. Epub 2013 Aug 5.

PMID:
23918947
[PubMed - indexed for MEDLINE]
Free Article
4.

Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare.

Griffiths RI, Gleeson ML, Danese MD, O'Hagan A.

Value Health. 2012 Jul-Aug;15(5):656-63. doi: 10.1016/j.jval.2012.03.1388. Epub 2012 Jun 22.

PMID:
22867774
[PubMed - indexed for MEDLINE]
5.

Trends in skin cancer knowledge, sun protection practices and behaviours in the Northern Ireland population.

Gavin A, Boyle R, Donnelly D, Donnelly C, Gordon S, McElwee G, O'Hagan A.

Eur J Public Health. 2012 Jun;22(3):408-12. doi: 10.1093/eurpub/ckr087. Epub 2011 Nov 16.

PMID:
22094579
[PubMed - indexed for MEDLINE]
Free Article
6.

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.

Griffiths RI, Barron RL, Gleeson ML, Danese MD, O'Hagan A, Chia VM, Legg JC, Lyman GH.

Pharmacoeconomics. 2012 Feb 1;30(2):103-18. doi: 10.2165/11589440-000000000-00000.

PMID:
21967155
[PubMed - indexed for MEDLINE]
7.

Designing a non-inferiority study in kidney transplantation: a case study.

Witte S, Schmidli H, O'Hagan A, Racine A.

Pharm Stat. 2011 Sep-Oct;10(5):427-32. doi: 10.1002/pst.511. Epub 2011 Sep 16.

PMID:
21928323
[PubMed - indexed for MEDLINE]
8.

Review of statistical methods for analysing healthcare resources and costs.

Mihaylova B, Briggs A, O'Hagan A, Thompson SG.

Health Econ. 2011 Aug;20(8):897-916. doi: 10.1002/hec.1653. Epub 2010 Aug 27. Review.

PMID:
20799344
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Trends in reported sun bed use, sunburn, and sun care knowledge and attitudes in a U.K. region: results of a survey of the Northern Ireland population.

Boyle R, O'Hagan AH, Donnelly D, Donnelly C, Gordon S, McElwee G, Gavin A.

Br J Dermatol. 2010 Dec;163(6):1269-75. doi: 10.1111/j.1365-2133.2010.09977.x. Epub 2010 Sep 30.

PMID:
20716213
[PubMed - indexed for MEDLINE]
10.

A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.

Kharroubi SA, O'Hagan A, Brazier JE.

Stat Med. 2010 Jul 10;29(15):1622-34. doi: 10.1002/sim.3874.

PMID:
20209481
[PubMed - indexed for MEDLINE]
11.

Public at risk: a survey of sunbed parlour operating practices in Northern Ireland.

Gavin A, Donnelly C, Devlin A, Devereux C, O'Callaghan G, McElwee G, Gordon S, Crossan T, McMahon N, Loan P, Martin S, McPeak L, Caughey J, O'Hagan AH.

Br J Dermatol. 2010 Mar;162(3):627-32. doi: 10.1111/j.1365-2133.2009.09591.x. Epub 2009 Nov 18.

PMID:
19922531
[PubMed - indexed for MEDLINE]
12.

The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation.

Nixon RM, O'Hagan A, Oakley J, Madan J, Stevens JW, Bansback N, Brennan A.

Pharm Stat. 2009 Oct-Dec;8(4):371-89. doi: 10.1002/pst.368.

PMID:
19340851
[PubMed - indexed for MEDLINE]
13.

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.

Pickin M, Cooper CL, Chater T, O'Hagan A, Abrams KR, Cooper NJ, Boggild M, Palace J, Ebers G, Chilcott JB, Tappenden P, Nicholl J.

BMC Neurol. 2009 Jan 6;9:1. doi: 10.1186/1471-2377-9-1.

PMID:
19126193
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Why licensing authorities need to consider the net value of new drugs in assigning review priorities: addressing the tension between licensing and reimbursement.

McCabe C, Claxton K, O'Hagan A.

Int J Technol Assess Health Care. 2008 Spring;24(2):140-5. doi: 10.1017/S0266462308080197.

PMID:
18400115
[PubMed - indexed for MEDLINE]
15.

Calculating partial expected value of perfect information via Monte Carlo sampling algorithms.

Brennan A, Kharroubi S, O'hagan A, Chilcott J.

Med Decis Making. 2007 Jul-Aug;27(4):448-70.

PMID:
17761960
[PubMed - indexed for MEDLINE]
16.

Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA.

O'Hagan A, Stevenson M, Madan J.

Health Econ. 2007 Oct;16(10):1009-23.

PMID:
17173339
[PubMed - indexed for MEDLINE]
17.

Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method.

Kharroubi S, Brazier JE, O'Hagan A.

Soc Sci Med. 2007 Mar;64(6):1242-52. Epub 2006 Dec 8.

PMID:
17157971
[PubMed - indexed for MEDLINE]
18.

Modelling SF-6D health state preference data using a nonparametric Bayesian method.

Kharroubi SA, Brazier JE, Roberts J, O'Hagan A.

J Health Econ. 2007 May 1;26(3):597-612. Epub 2006 Oct 27.

PMID:
17069909
[PubMed - indexed for MEDLINE]
19.

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.

Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. Review.

PMID:
16796930
[PubMed - indexed for MEDLINE]
Free Article
20.

Using rank data to estimate health state utility models.

McCabe C, Brazier J, Gilks P, Tsuchiya A, Roberts J, O'Hagan A, Stevens K.

J Health Econ. 2006 May;25(3):418-31. Epub 2006 Feb 24.

PMID:
16499981
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk